Delivery Order SPE2DR25D2014-SPE2DR26FZ67E
Award Date 11/10/25
Potential Completion Date 11/12/25
Potential Value $6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for pharmaceutical supplies under a firm fixed-price contract valued at $2,454.63. The specific product being delivered is Myrbetriq ER 50 mg tablets in a quantity of 90, with an ultimate completion date of August 15, 2025. This non-set-aside award, issued on August 14, 2025, represents a competitive procurement action with the place of performance located in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 18, 2025, valued at $27,386.76 for the supply of Myrbetriq ER 50 mg tablets (90-count). The contract was awarded on a competitive, non-set-aside basis with firm fixed pricing and an ultimate completion date of July 21, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on October 29, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count packages) under a firm fixed-price contract valued at $12,941.32, with completion targeted for October 30, 2025. This non-set-aside award was competitively awarded and represents a single delivery order against the company's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $20,113.02 by the Defense Logistics Agency Medical Supply Chain on June 27, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This firm fixed-price, competitively awarded delivery order is set to be completed by June 30, 2025, with performance at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp has been awarded a delivery order from the Defense Logistics Agency for $12,459.55 to supply Myrbetriq ER 50 mg tablets in a 90-count quantity. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and utilizes firm fixed pricing with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order represents a competitive...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $28,170.24 by the Defense Logistics Agency (DLA) for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 1, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency on July 28, 2025, for MYRBETRIQ ER 50 MG tablets (90-count supply) valued at $10,533.16. This contract award operates under a firm fixed-price structure with no set-aside designation, indicating competitive procurement. The delivery order was completed on July 29, 2025, with performance taking place at the vendor's corporate office location in...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on May 12, 2025, for the supply of MYRBETRIQ ER 50 mg tablets (90-count quantity) with a contract ceiling value of $35,186.14. The award is a firm fixed price delivery order with an ultimate completion date of May 13, 2025, and represents a non-competitive, non-set-aside award. Performance will be conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $17,760.65 on October 20, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed price delivery order with an ultimate completion date of October 21, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under the company's larger...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Myrbetriq ER 25 mg tablets (90-count supply) with a contract ceiling value of $7,101.28. The award, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...